Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
Authors
Keywords
Irritable Bowel Syndrome, Rifaximin, Rifamycin, Small Intestinal Bacterial Overgrowth, Duodenal Aspirate
Journal
Annals of Clinical Microbiology and Antimicrobials
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-10-16
DOI
10.1186/s12941-014-0049-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review article: small intestinal bacterial overgrowth - prevalence, clinical features, current and developing diagnostic tests, and treatment
- (2013) E. Grace et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Performance Characteristics of qPCR Assays Targeting Human- and Ruminant-AssociatedBacteroidetesfor Microbial Source Tracking across Sixteen Countries on Six Continents
- (2013) Georg H. Reischer et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months
- (2012) P. Meyrat et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- (2011) Stacy B Menees et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Double-Blind Randomized Controlled Trial of Rifaximin for Persistent Symptoms in Patients with Celiac Disease
- (2011) Matthew S. Chang et al. DIGESTIVE DISEASES AND SCIENCES
- Double-blind, Placebo-controlled Antibiotic Treatment Study of Small Intestinal Bacterial Overgrowth in Children With Chronic Abdominal Pain
- (2011) Brynie Slome Collins et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
- (2011) Mark Pimentel et al. NEW ENGLAND JOURNAL OF MEDICINE
- How to Interpret Hydrogen Breath Tests
- (2011) Uday C Ghoshal Journal of Neurogastroenterology and Motility
- Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth
- (2010) M. Furnari et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
- (2010) Lucio Lombardo et al. Clinical Gastroenterology and Hepatology
- Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS
- (2010) D. Yu et al. GUT
- Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
- (2009) Alexander C. Ford et al. Clinical Gastroenterology and Hepatology
- Review of rifaximin as treatment for SIBO and IBS
- (2009) Mark Pimentel EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin
- (2009) Sergio Peralta et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Small Intestinal Bacterial Overgrowth in Patients Suffering From Scleroderma: Clinical Effectiveness of Its Eradication
- (2008) Andrea Parodi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started